Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (801-810 of 1,023) with videos related to

Pageof 103
Sort By:
Journal of the American College of Cardiology|September 24, 2013
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarinZiad Hijazi, Lars Wallentin, Agneta Siegbahn, et al.
Lancet (London, England)|October 7, 2018
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F Hernandez, Jennifer B Green, Salim Janmohamed, et al.
JAMA Network Open|September 16, 2020
Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY TrialsZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
Journal of the American Heart Association|August 23, 2023
Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MIXiaowen Wang, Karola S Jering, Maja Cikes, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 10, 2020
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fractionLi Shen, Pardeep S Jhund, Inder S Anand, et al.
Circulation|February 19, 2019
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body WeightStefan H Hohnloser, Marat Fudim, John H Alexander, et al.
European Heart Journal|December 25, 2004
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trialsMarino Labinaz, Jasmine Mathias, Karen Pieper, et al.
European Heart Journal|September 16, 2015
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trialDragos Vinereanu, Susanna R Stevens, John H Alexander, et al.
Journal of the American College of Cardiology|September 30, 2017
Physical Activity and Mortality in Patients With Stable Coronary Heart DiseaseRalph A H Stewart, Claes Held, Nermin Hadziosmanovic, et al.
Atherosclerosis|April 1, 2008
ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary interventionSvati H Shah, Elizabeth R Hauser, David Crosslin, et al.
Pageof 103

Showing results (801-810 of 1,023) with videos related to

Sort By:
Pageof 103
Journal of the American College of Cardiology|September 24, 2013
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarinZiad Hijazi, Lars Wallentin, Agneta Siegbahn, et al.
Lancet (London, England)|October 7, 2018
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F Hernandez, Jennifer B Green, Salim Janmohamed, et al.
JAMA Network Open|September 16, 2020
Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY TrialsZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
Journal of the American Heart Association|August 23, 2023
Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MIXiaowen Wang, Karola S Jering, Maja Cikes, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 10, 2020
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fractionLi Shen, Pardeep S Jhund, Inder S Anand, et al.
Circulation|February 19, 2019
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body WeightStefan H Hohnloser, Marat Fudim, John H Alexander, et al.
European Heart Journal|December 25, 2004
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trialsMarino Labinaz, Jasmine Mathias, Karen Pieper, et al.
European Heart Journal|September 16, 2015
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trialDragos Vinereanu, Susanna R Stevens, John H Alexander, et al.
Journal of the American College of Cardiology|September 30, 2017
Physical Activity and Mortality in Patients With Stable Coronary Heart DiseaseRalph A H Stewart, Claes Held, Nermin Hadziosmanovic, et al.
Atherosclerosis|April 1, 2008
ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary interventionSvati H Shah, Elizabeth R Hauser, David Crosslin, et al.
Pageof 103